针对乙型肝炎病毒感染的CRISPR/Cas9治疗方法
Bo Cai1, Shixue Chang2, Yuhan Tian2
1Center of Medical Genetics, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, PR. China.
Immunity, inflammation and disease
|May 30, 2023
概括
基因编辑CRISPR/Cas9提供了一个有希望的新策略,通过向病毒DNA来对抗乙型肝炎病毒 (HBV) 感染. 这种方法显示出潜力使持久性HBVcccDNA无活化,这是慢性感染的关键挑战.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子病毒学分子病毒学
- 基因治疗 基因治疗
背景情况:
- 乙型肝炎病毒 (HBV) 感染是全球主要的健康问题,导致肝硬化和肝癌.
- 目前的治疗方法可以控制HBV复制,但无法消除持久的ccccDNA,因此需要新的策略.
- 克里斯普尔/卡斯9技术为消除HBV感染提供了一个潜在的解决方案.
研究的目的:
- 审查CRISPR/Cas9应用在B型肝炎病毒方面的进展.
- 讨论针对肝脏中的HBV的各种传递载体.
- 总结目前关于CRISPR/Cas9对HBV的临床前和临床研究状况.
主要方法:
- 对针对乙型肝炎病毒的CRISPR/Cas9系统的科学文献的审查.
- 对用于肝脏输送CRISPR/Cas9组件的不同载体系统的分析.
- 对基于CRISPR/Cas9的HBV疗法的临床前和临床研究结果的评估.
主要成果:
- 通过CRISPR/Cas9基因编辑,可以有效地抑制HBV复制.
- 某些CRISPR/Cas9策略显示出潜力使持久性HBVcccDNA无活化.
- 目前正在探索各种传递载体,以有效向肝细胞.
结论:
- 克里斯普尔/卡斯9基因编辑作为慢性乙型肝炎的治疗策略具有重大前景.
- 进一步的研究和临床试验对于优化交付和疗效至关重要.
- 这项技术可以克服当前针对HBV的抗病毒疗法的局限性.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.3K
09:45Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes
Published on: June 2, 2022
2.7K
相关概念视频
CRISPR/Cas9 Genome Editing
79
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
79
CRISPR
52.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.5K
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
The Antiviral System of Bacteria and Archaea: CRISPR
63
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
63
